Relx (NYSE:RELX) was downgraded by analysts at Deutsche Bank from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, The Fly reports.
Separately, BNP Paribas raised Relx from an “underperform” rating to an “outperform” rating in a research report on Thursday, December 6th.
RELX stock opened at $22.37 on Wednesday. The company has a current ratio of 0.41, a quick ratio of 0.37 and a debt-to-equity ratio of 2.39. The stock has a market capitalization of $23.56 billion, a price-to-earnings ratio of 21.72 and a beta of 0.55. Relx has a 1 year low of $19.23 and a 1 year high of $23.11.
Several hedge funds and other institutional investors have recently modified their holdings of RELX. BlackRock Inc. raised its position in shares of Relx by 112,684.7% during the 4th quarter. BlackRock Inc. now owns 1,066,943 shares of the technology company’s stock worth $21,894,000 after acquiring an additional 1,065,997 shares in the last quarter. Morgan Stanley raised its position in shares of Relx by 119.6% during the 3rd quarter. Morgan Stanley now owns 1,580,722 shares of the technology company’s stock worth $33,085,000 after acquiring an additional 861,045 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Relx by 473.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 834,878 shares of the technology company’s stock worth $17,474,000 after acquiring an additional 689,380 shares in the last quarter. Karp Capital Management Corp acquired a new stake in shares of Relx during the 1st quarter worth about $13,161,000. Finally, Millennium Management LLC raised its position in shares of Relx by 365.9% during the 1st quarter. Millennium Management LLC now owns 817,925 shares of the technology company’s stock worth $17,086,000 after acquiring an additional 642,369 shares in the last quarter. 4.03% of the stock is currently owned by institutional investors and hedge funds.
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Story: What is a Roth IRA?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.